Tesofensine 80mg Research Compound
Tesofensine is a triple monoamine reuptake inhibitor (serotonin, dopamine, and norepinephrine) originally developed by NeuroSearch for neurodegenerative disease before attracting significant research interest for CNS-mediated metabolic and appetite regulation. As an oral small molecule rather than an injectable peptide, tesofensine occupies a distinct mechanistic niche in metabolic research, acting centrally through monoaminergic pathways rather than peripheral incretin receptors. This 80mg vial provides research-grade tesofensine at ≥99% purity, HPLC and MS/MS verified per batch.
Research Background
Tesofensine is characterised in the published literature as a centrally acting monoamine reuptake inhibitor. Research interest centres on its activity at the serotonin, dopamine and norepinephrine transporters, and on how CNS-mediated regulatory pathways differ mechanistically from the peripheral incretin pathways targeted by GLP-1 receptor agonists.
For a full breakdown of tesofensine’s mechanism, and mechanistic comparison with GLP-1 agonists, see our Tesofensine Research Guide.
Compound Specifications
- Format: Lyophilized powder
- Purity: ≥99% (HPLC verified)
- Quantity: 80mg per vial
- Storage: −20°C, protected from light
- Active compound: Tesofensine
- CAS Number: 402856-42-2
Certificate of Analysis
All tesofensine vials are third-party tested by independent ISO-certified laboratories. HPLC and MS/MS validation performed per batch. COA available on request.
For research and laboratory use only. Not for human consumption. Not intended to diagnose, treat, cure, or prevent any disease.
